135 related articles for article (PubMed ID: 35425398)
1. Design, synthesis and evaluation of 3-phenoxypyrazine-2-carboxamide derivatives as potent TGR5 agonists.
Zhao S; Wang L; Wang J; Wang C; Zheng S; Fu Y; Li Y; Chen WD; Hou R; Yang D; Wang YD
RSC Adv; 2022 Jan; 12(6):3618-3629. PubMed ID: 35425398
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of 1-benzyl-1H-imidazole-5-carboxamide derivatives as potent TGR5 agonists.
Zhao S; Li X; Wang L; Peng W; Ye W; Li W; Wang YD; Chen WD
Bioorg Med Chem; 2021 Feb; 32():115972. PubMed ID: 33440321
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Orally Efficacious Tetrahydrobenzimidazoles as TGR5 Agonists for Type 2 Diabetes.
Zhang X; Wall M; Sui Z; Kauffman J; Hou C; Chen C; Du F; Kirchner T; Liang Y; Johnson DL; Murray WV; Demarest K
ACS Med Chem Lett; 2017 May; 8(5):560-565. PubMed ID: 28523111
[TBL] [Abstract][Full Text] [Related]
4. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
Huang S; Ma S; Ning M; Yang W; Ye Y; Zhang L; Shen J; Leng Y
Metabolism; 2019 Oct; 99():45-56. PubMed ID: 31295453
[TBL] [Abstract][Full Text] [Related]
5. OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition.
Ma SY; Ning MM; Zou QA; Feng Y; Ye YL; Shen JH; Leng Y
Acta Pharmacol Sin; 2016 Sep; 37(10):1359-1369. PubMed ID: 27264313
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and antidiabetic activity of 4-phenoxynicotinamide and 4-phenoxypyrimidine-5-carboxamide derivatives as potent and orally efficacious TGR5 agonists.
Duan H; Ning M; Chen X; Zou Q; Zhang L; Feng Y; Zhang L; Leng Y; Shen J
J Med Chem; 2012 Dec; 55(23):10475-89. PubMed ID: 23148522
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist.
Agarwal S; Patil A; Aware U; Deshmukh P; Darji B; Sasane S; Sairam KV; Priyadarsiny P; Giri P; Patel H; Giri S; Jain M; Desai RC
ACS Med Chem Lett; 2016 Jan; 7(1):51-5. PubMed ID: 26819665
[TBL] [Abstract][Full Text] [Related]
9. The Dietary Furocoumarin Imperatorin Increases Plasma GLP-1 Levels in Type 1-Like Diabetic Rats.
Wang LY; Cheng KC; Li Y; Niu CS; Cheng JT; Niu HS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29084156
[TBL] [Abstract][Full Text] [Related]
10. Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats.
Lo SH; Li Y; Cheng KC; Niu CS; Cheng JT; Niu HS
Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1097-1104. PubMed ID: 28756460
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.
Agarwal S; Sasane S; Kumar J; Deshmukh P; Bhayani H; Giri P; Giri S; Soman S; Kulkarni N; Jain M
Bioorg Med Chem Lett; 2018 Jun; 28(10):1849-1852. PubMed ID: 29655980
[TBL] [Abstract][Full Text] [Related]
12. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
[TBL] [Abstract][Full Text] [Related]
13. Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice.
Finn PD; Rodriguez D; Kohler J; Jiang Z; Wan S; Blanco E; King AJ; Chen T; Bell N; Dragoli D; Jacobs JW; Jain R; Leadbetter M; Siegel M; Carreras CW; Koo-McCoy S; Shaw K; Le C; Vanegas S; Hsu IH; Kozuka K; Okamoto K; Caldwell JS; Lewis JG
Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G412-G424. PubMed ID: 30605011
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation.
Kim K; Park M; Lee YM; Rhyu MR; Kim HY
Arch Pharm Res; 2014; 37(9):1193-200. PubMed ID: 24590628
[TBL] [Abstract][Full Text] [Related]
15. A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic Mice.
Zheng C; Zhou W; Wang T; You P; Zhao Y; Yang Y; Wang X; Luo J; Chen Y; Liu M; Chen H
PLoS One; 2015; 10(7):e0134051. PubMed ID: 26208278
[TBL] [Abstract][Full Text] [Related]
16. Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists.
Miyata S; Kawashima Y; Sakai M; Matsubayashi M; Motoki K; Miyajima Y; Watanabe Y; Chikamatsu N; Taniguchi T; Tokuyama R
Sci Rep; 2021 Apr; 11(1):9196. PubMed ID: 33911126
[TBL] [Abstract][Full Text] [Related]
17. Identification of key amino acid residues in the hTGR5-nomilin interaction and construction of its binding model.
Sasaki T; Mita M; Ikari N; Kuboyama A; Hashimoto S; Kaneko T; Ishiguro M; Shimizu M; Inoue J; Sato R
PLoS One; 2017; 12(6):e0179226. PubMed ID: 28594916
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold.
Zhu J; Ning M; Guo C; Zhang L; Pan G; Leng Y; Shen J
Eur J Med Chem; 2013 Nov; 69():55-68. PubMed ID: 24007860
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizic acid increases glucagon like peptide-1 secretion via TGR5 activation in type 1-like diabetic rats.
Wang LY; Cheng KC; Li Y; Niu CS; Cheng JT; Niu HS
Biomed Pharmacother; 2017 Nov; 95():599-604. PubMed ID: 28881290
[TBL] [Abstract][Full Text] [Related]
20. A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis.
Pan Q; Lin S; Li Y; Liu L; Li X; Gao X; Yan J; Gu B; Chen X; Li W; Tang X; Chen C; Guo L
EBioMedicine; 2021 Jan; 63():103202. PubMed ID: 33421947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
